Product Images Rivastigmine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 24 images provide visual information about the product associated with Rivastigmine NDC 65162-825 by Amneal Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a Pouch Rivastigmine Patch, which is also known as Rivastigmine Transdermal System. The strength of this medication is 4.6 mg per 24 hours. Protective liners may also be included.*
This text appears to be a list of body parts where an injury or pain may exist. The list includes the left or right upper arm, left or right side of chest, front I, left or right upper back, and left or right lower back. It may be part of a medical form or questionnaire.*
This is a description for a Rivastigmine Transdermal System for transdermal use. It contains one system prescription for non-varnish area. It is essential to read the enclosed package for proper application of the patch. The recommended usage is once a day, and a new patch should be applied every 24 hours. Applying the patch to the skin area is recommended immediately after it is removed from the pouch. The location of each new patch should be changed. Children should not reach the patch, and adults should keep it for discarding the patch after use. The pouch can be stored between 20°C to 25°C (66°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). The manufacturer of the product is Amneal Pharmaceuticals located in Bridgewater, NJ. However, any readable text from the image is missing.*
This is a set of instructions with more details about a product called Rivastigmine Transdermal System, which is a treatment containing 9 mg of rivastigmine, provided in 5 CR units that release 4.6 mg every 24 hours. The product should be used transdermally, with users applying a new patch after discarding the old one, keeping the product out of reach of children and not using any visibly damaged products. The packaging contains the manufacturer's phone number for more information.*
This text appears to be a description of a medication called "Rivastigmine Transdermal System" that is administered through a patch for transdermal use. The text includes instructions for application, such as wearing only one patch at a time and replacing it with a new patch every 24 hours. The patch should not be cut and should be applied immediately to intact skin. The text also contains information on storage and warns that the medication should be kept out of reach of children. The medication is distributed by Amneal Pharmaceuticals based in Bridgewater, NJ.*
The text is a set of instructions and guidelines for the use and disposal of the Rivastigmine Transdermal System, a medication patch used for the treatment of Alzheimer's Disease. It contains information on the dosage, administration, inactive components, and storage of the patch. The instructions also provide guidance on how to safely discard the used patches and keep them out of the reach of children. Contact information for Amneal Pharmaceuticals is also provided for more information.*
This is the description of Rivastigle Transdermal System, a type of medication delivered through the skin. It is for transdermal use only and comes in a pouch that contains one system. The medication should not be cut and only one patch must be applied at a time. The patch should be changed every 24 hours, and the location of each new patch must be changed. The medication should be kept out of the reach of children, and the pouch must be retained for discarding the patch after use. The medication should be stored at 20° to 25°C (68° to 77°F). This medication is distributed by Amneal Pharmaceuticals in Bridgewater, NJ.*
The text provides instructions for discarding the Rivastigmine Transdermal System patch. The patch should be replaced every 24 hours, and the used patch should be disposed of safely out of reach of children. The text also contains information on the inactive components of the patch and on dosage and administration, and provides a website and contact number for further information.*
This text provides instructions on how to use Rivastigmine Transdermal System, a patch medication for treatment. It advises to follow the doctor's instructions and apply only one patch at a time, on clean, dry, hairless, and intact skin at the back, upper arm, or chest. It instructs to cut the pouch, peel one side of the protective liner, apply the sticky side to the skin, peel off the second side, and press the patch firmly to the skin. Lastly, it reminds to wash hands after applying the patch.*
This is a chart showing the concentration of Rivastigmine in ng/mL for three different dosages (4.6, 9.5, and 13.3mg/24 hours) with sample sizes of 22, 22, and 19 respectively, at various time points.*
This appears to be a chart or graph displaying results from a study involving two different treatments using "Rivasigmine patch 4.6 mg/24 hr" and "Rivastigmine patch 9.5 mg/24 hr". However, the text is not entirely clear and may not be useful without additional information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.